Health Letter, October 2021
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
Acetaminophen tablets, regular-strength pain reliever, 325 mg, 100-count bottle. Distributed by: Walmart Inc. Lot #: S210240, exp. date: 03/2023.
Carvedilol tablets, 25 mg, 180- or 500-tablet bottles. Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc. Lot #: Z006279, exp. date: 12/31/2022; Lot # B1273286-071521, exp. date: 07/31/2022.
Clopidogrel tablets, 75 mg, 500-count bottle. Manufactured by: Macleods Pharmaceutical Ltd. Lot #: BCA82021A, exp. date: 06/2023.
Cyclobenzaprine hydrochloride tablets, 7.5 mg, 100-count bottles. Manufactured by: Actavis Laboratories FL, Inc. Lot #: 1408821A, exp. date: 08/2023 (labeler – Teva); Lot #: 1408822A, exp. date: 08/2023 (labeler – Casper); Lot #: 1408824A, exp. date: 08/2023 (labeler – Rising).
Naproxen sodium tablets, 220 mg, Caplet. Manufactured by: Granules India Limited. Lot #: 7620060a.
Tizanidine HCl tablets, 4 mg, 150-count bottles. Manufactured by: Dr. Reddy’s Laboratories Limited. Lot #: T2000471, exp. date: 09/2023.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.